Mosaic ImmunoEngineering, Inc.
CPMV
$0.67
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.57% | -20.65% | -29.65% | -34.01% | -26.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.12% | -29.95% | -38.48% | -41.60% | -35.00% |
| Operating Income | 24.12% | 29.95% | 38.48% | 41.60% | 35.00% |
| Income Before Tax | 16.35% | 25.46% | 37.35% | 43.17% | 9.51% |
| Income Tax Expenses | 0.00% | 0.00% | -- | -- | -- |
| Earnings from Continuing Operations | 16.30% | 25.39% | 36.90% | 42.77% | 9.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.30% | 25.39% | 36.90% | 42.77% | 9.25% |
| EBIT | 24.12% | 29.95% | 38.48% | 41.60% | 35.00% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 16.25% | 25.27% | 36.85% | 42.77% | 9.27% |
| Normalized Basic EPS | 16.38% | 25.22% | 37.08% | 42.84% | 34.70% |
| EPS Diluted | 13.89% | 23.00% | 35.08% | 42.56% | 10.28% |
| Normalized Diluted EPS | 16.38% | 25.22% | 37.08% | 42.84% | 31.84% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -4.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |